Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS.
Fingolimod treatment promotes regulatory phenotype and function of B cells.
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
[Autophagy and its role in protective and damaging inflammatory response].
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Biologically plausible and evidence-based risk intervals in immunization safety research.
Information regarding Active Biotech's candidate drug laquinimod
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis.
Non-local robust detection of DTI white matter differences with small databases.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Value of NMO-IgG determination at the time of presentation as CIS.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Life-threatening asthma attack during prolonged fingolimod treatment: case report.

Pages